CORDIS Project

A diagnostic test to improve surveillance and care of COVID-19 patients

COVIRNA·101016072·H2020

Funding breakdown and partner intelligence are Premium

Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1

Upgrade

Start free • Cancel anytime • 14-day refund guarantee

View on CORDIS DOI grant

Funding data

Programme: Horizon 2020
Participants: 4
Start - End: 01/11/2020 — 30/04/2023
Status: CLOSED

Summary

COVIRNA develops a prognostic system using cardiovascular biomarkers and artificial intelligence to predict severe outcomes in COVID-19 patients. This innovative tool aims to identify individuals at high risk of cardiovascular events, enhancing patient care and management during the pandemic and beyond.

Objective

Coronavirus disease 2019 (COVID-19) caused by infection with SARS coronavirus 2 (SARS-CoV-2) has reached pandemic proportions with more than 7 million people infected and 0.4 million people killed worldwide.

Death rates are accentuated by cardiovascular comorbidities and arrhythmias leading to unexpected major cardiovascular events.

Being able to identify COVID-19 patients at risk of developing cardiovascular events leading to death would allow improving surveillance and care.

Currently, there i…

Full objective and premium intelligence

Upgrade to Premium for the complete objective, AI summary, similar projects, consortium analytics, OpenAlex context, and funding breakdown.

Upgrade Sign in

Start free • Cancel anytime • 14-day refund guarantee

Coordinator

LIH

LUXEMBOURG INSTITUTE OF HEALTH

Country: Luxembourg, Strassen
Organization type: Research institute
Activity type: Research Organisations
SME: No

Network and participants(4 participants)

Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.

Firalis
France, Huningue
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
participant
FIRALIS MOLECULAR PRECISION SA
France, Huningue
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
thirdparty
uni.lu
Luxembourg, ESCH-SUR-ALZETTE
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
participant
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
United Kingdom, LONDON
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
participant

4 participants shown of 16

Upgrade Sign in

Start free • Cancel anytime • 14-day refund guarantee

Partner & research intelligence

Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.

Consortium analytics and research context are Premium

Upgrade Sign in

Start free • Cancel anytime • 14-day refund guarantee

CORDIS call / funding scheme

Programme: H2020
Call: H2020-SC1-PHE-CORONAVIRUS-2020-2
Sub call: H2020-SC1-PHE-CORONAVIRUS-2020-2-CNECT
Funding scheme: IA - Innovation action
Domain note: This block describes the CORDIS project call context. Live open opportunities are managed in the Funding & Tenders domain.

Fields of Science (EuroSciVoc)

Guests see up to 5 EuroSciVoc fields.

Medical and health sciencesBasic medicineMedicinal chemistry
Medical and health sciencesClinical medicineCardiologyCardiovascular diseasesCardiac arrhythmia
Medical and health sciencesHealth sciencesInfectious diseasesRNA virusesCoronaviruses
Natural sciencesComputer and information sciencesArtificial intelligence
Social sciencesSociologyDemographyMortality

Topic

Guests see up to 5 topics.

SC1-PHE-CORONAVIRUS-2020-2B

Keywords

Guests see up to 5 keywords.

biomarkers cardiovascular long non-coding RNA COVID-19 prognosis AI